The treatment of paraprotein-related kidney disease.

@article{Hutchison2017TheTO,
  title={The treatment of paraprotein-related kidney disease.},
  author={C. A. Hutchison and Fei Xiong and Peter N. Mollee},
  journal={Current opinion in nephrology and hypertension},
  year={2017},
  volume={26 6},
  pages={477-483}
}
PURPOSE OF REVIEW Myeloma kidney and amyloid light-chain (AL) amyloidosis remain the principal kidney complications of paraproteins. In this review, we update readers to many of the recent advances which have occurred in the care and outcomes for patients with these presentations. RECENT FINDINGS Myeloma kidney has historically caused a severe acute kidney injury with very poor outcomes. The combination of new diagnostic techniques, enabling a rapid diagnosis and novel chemotherapy agents has… CONTINUE READING